BONE 3.20 Bacterin Intl Hldgs $BONE Hit a 52 week low of 3.15 Closing the day 10:43 at 3.20 -0.33 -9.35% With a day low of 3.15 and a total volume of 32,844.
BONE Recent Posts: http://investorshangout.com/Bacterin-Internat...ONE-56109/
BONE Bacterin Intl Hldgs Recent Headline News
Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference
GlobeNewswire - Mon Nov 17, 11:54AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday, November 20, 2014 at 10:30am ET.
BONE: 3.20 (-0.33)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:47AM CST
CADC: 5.40 (-0.20), ANV: 1.84 (+0.17), BONE: 3.20 (-0.33), WLH: 19.04 (-0.10), CLDX: 17.38 (-0.87), ENZY: 8.30 (-0.06), TGEN: 6.25 (-0.01), CHOP: 2.05 (-0.13), MSBF: 9.91 (-0.32), NVGN: 1.60 (-0.05), DWA: 22.36 (+0.05), WHX: 2.42 (-0.16), VYFC: 19.75 (unch), VGGL: 3.68 (-0.05), SNSS: 2.20 (-0.11), DNR: 9.91 (-0.10), MOBI: 6.23 (-0.15), VPCO: 1.65 (+0.12), FOLD: 6.40 (-0.30), ATEA: 1.47 (unch)
Bacterin down after delisting notice
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:30AM CST
BONE: 3.20 (-0.33)
Bacterin Receives Delisting Notice From NYSE MKT
GlobeNewswire - Fri Nov 14, 4:16PM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE MKT" or the "Exchange"
because the Company did not cure its non-compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE MKT Company Guide by the end of the maximum 18 month compliance plan period, which expired on November 13, 2014. Therefore, the Company's common stock is subject to delisting from the Exchange.
BONE: 3.20 (-0.33)
Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman
GlobeNewswire - Tue Nov 11, 6:30AM CST
Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's After the Bell with Liz Claman at approximately 4:15 PM/ET on Tuesday, November 11, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products.
BONE: 3.20 (-0.33)
Bacterin Internationals' (BONE) CEO Dan Goldberger on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 2:39PM CST
BONE: 3.20 (-0.33)
Bacterin International beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:57PM CST
BONE: 3.20 (-0.33)
Bacterin Announces Further Expansion of Its Sales Force
GlobeNewswire - Wed Nov 05, 6:46AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced three senior additions to its Field Sales Organization.
BONE: 3.20 (-0.33)
Bacterin to Showcase New Product Line at the North American Spine Society Annual Meeting
GlobeNewswire - Tue Nov 04, 6:39AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced the first public presentation of a unique new product line for use in spinal procedures, the 3Demin(TM) product family, which will be displayed at the 2014 North American Spine Society (NASS) Annual Meeting.
BONE: 3.20 (-0.33)
Photo Release -- Bacterin Announces New Demineralized Bone Matrix Constructs for Spine Applications
GlobeNewswire - Wed Oct 29, 6:28AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the release of two unique new products for use in spinal procedures, 3Demin(TM) Boats and 3Demin(TM) Strips. These products complement Bacterin's existing bone graft portfolio as our new technology allows us to provide larger constructs suitable for multi-level spinal fusion procedures.
BONE: 3.20 (-0.33)
Bacterin Awarded Grant From the Montana Board of Research and Commercialization Technology
GlobeNewswire - Mon Oct 27, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, has been awarded a grant from the Montana Board of Research and Commercialization Technology (MBRCT) in the amount of $192,484 for the development and commercialization of a novel regenerative medicine technology.
BONE: 3.20 (-0.33)
Bacterin reports November 5
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:21PM CDT
BONE: 3.20 (-0.33)
Bacterin to Report Third Quarter 2014 Financial Results on November 5, 2014
GlobeNewswire - Thu Oct 23, 2:58PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended September 30, 2014, on November 5, 2014 at the close of the financial markets.
BONE: 3.20 (-0.33)
Bacterin Presents Preclinical Results of an Efficacious Antimicrobial Orthopedic Device Coating
GlobeNewswire - Wed Oct 22, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, presented preclinical results of a robust and efficacious antimicrobial coating for orthopedic hardware at the 2014 Orthopaedic Trauma Association (OTA) Annual Meeting.
BONE: 3.20 (-0.33)
Bacterin Announces 3Demin(TM) Cortical Fibers
GlobeNewswire - Mon Oct 20, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the launch of a demineralized allograft, 3Demin(TM) Cortical Fibers.
BONE: 3.20 (-0.33)
CORRECTING AND REPLACING -- Bacterin Announces Preliminary Third Quarter 2014 Revenue
GlobeNewswire - Thu Oct 16, 9:46AM CDT
In a release issued on Tuesday, October 14th 2014 by Bacterin International Holdings, Inc. (NYSE MKT:BONE), there was an error in the third paragraph. Please note that the final sentence of the third paragraph should read, "We are now starting to realize the benefits of these investments and we expect to see our revenue accelerate during the fourth quarter of 2014 and throughout 2015."
BONE: 3.20 (-0.33)
Bacterin Announces Preliminary Third Quarter 2014 Revenue
GlobeNewswire - Tue Oct 14, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary, unaudited revenue for the third quarter of 2014.
BONE: 3.20 (-0.33)
Volcano Corp Banks on IVUS Portfolio amid Several Odds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 1:30PM CDT
On Oct 10, we issued an updated research report on leading precision guided therapy tools provider, Volcano Corporation (VOLC).
BONE: 3.20 (-0.33), HNSN: 0.80 (unch), VOLC: 11.20 (+0.12), EW: 126.80 (+0.57)
Bacterin CEO Dan Goldberger to be Guest on Fox Business Network's Opening Bell With Maria Bartiromo
GlobeNewswire - Thu Oct 02, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's Opening Bell with Maria Bartiromo at approximately 10:40 AM/ET on Friday, October 3, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products.
BONE: 3.20 (-0.33)
Edwards Lifesciences Up to Buy on Solid Q2, Strong Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 1:50PM CDT
Recently, Zacks Investment Research upgraded Edwards Lifesciences Corporation (EW) to a Zacks Rank #2 (Buy).
BONE: 3.20 (-0.33), HNSN: 0.80 (unch), EW: 126.80 (+0.57), HOLX: 26.61 (+0.24)
BONE Recent Posts: http://investorshangout.com/Bacterin-Internat...ONE-56109/
BONE Bacterin Intl Hldgs Recent Headline News
Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference
GlobeNewswire - Mon Nov 17, 11:54AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday, November 20, 2014 at 10:30am ET.
BONE: 3.20 (-0.33)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:47AM CST
CADC: 5.40 (-0.20), ANV: 1.84 (+0.17), BONE: 3.20 (-0.33), WLH: 19.04 (-0.10), CLDX: 17.38 (-0.87), ENZY: 8.30 (-0.06), TGEN: 6.25 (-0.01), CHOP: 2.05 (-0.13), MSBF: 9.91 (-0.32), NVGN: 1.60 (-0.05), DWA: 22.36 (+0.05), WHX: 2.42 (-0.16), VYFC: 19.75 (unch), VGGL: 3.68 (-0.05), SNSS: 2.20 (-0.11), DNR: 9.91 (-0.10), MOBI: 6.23 (-0.15), VPCO: 1.65 (+0.12), FOLD: 6.40 (-0.30), ATEA: 1.47 (unch)
Bacterin down after delisting notice
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:30AM CST
BONE: 3.20 (-0.33)
Bacterin Receives Delisting Notice From NYSE MKT
GlobeNewswire - Fri Nov 14, 4:16PM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE MKT" or the "Exchange"
because the Company did not cure its non-compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE MKT Company Guide by the end of the maximum 18 month compliance plan period, which expired on November 13, 2014. Therefore, the Company's common stock is subject to delisting from the Exchange. BONE: 3.20 (-0.33)
Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman
GlobeNewswire - Tue Nov 11, 6:30AM CST
Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's After the Bell with Liz Claman at approximately 4:15 PM/ET on Tuesday, November 11, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products.
BONE: 3.20 (-0.33)
Bacterin Internationals' (BONE) CEO Dan Goldberger on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 2:39PM CST
BONE: 3.20 (-0.33)
Bacterin International beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:57PM CST
BONE: 3.20 (-0.33)
Bacterin Announces Further Expansion of Its Sales Force
GlobeNewswire - Wed Nov 05, 6:46AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced three senior additions to its Field Sales Organization.
BONE: 3.20 (-0.33)
Bacterin to Showcase New Product Line at the North American Spine Society Annual Meeting
GlobeNewswire - Tue Nov 04, 6:39AM CST
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced the first public presentation of a unique new product line for use in spinal procedures, the 3Demin(TM) product family, which will be displayed at the 2014 North American Spine Society (NASS) Annual Meeting.
BONE: 3.20 (-0.33)
Photo Release -- Bacterin Announces New Demineralized Bone Matrix Constructs for Spine Applications
GlobeNewswire - Wed Oct 29, 6:28AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the release of two unique new products for use in spinal procedures, 3Demin(TM) Boats and 3Demin(TM) Strips. These products complement Bacterin's existing bone graft portfolio as our new technology allows us to provide larger constructs suitable for multi-level spinal fusion procedures.
BONE: 3.20 (-0.33)
Bacterin Awarded Grant From the Montana Board of Research and Commercialization Technology
GlobeNewswire - Mon Oct 27, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, has been awarded a grant from the Montana Board of Research and Commercialization Technology (MBRCT) in the amount of $192,484 for the development and commercialization of a novel regenerative medicine technology.
BONE: 3.20 (-0.33)
Bacterin reports November 5
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:21PM CDT
BONE: 3.20 (-0.33)
Bacterin to Report Third Quarter 2014 Financial Results on November 5, 2014
GlobeNewswire - Thu Oct 23, 2:58PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended September 30, 2014, on November 5, 2014 at the close of the financial markets.
BONE: 3.20 (-0.33)
Bacterin Presents Preclinical Results of an Efficacious Antimicrobial Orthopedic Device Coating
GlobeNewswire - Wed Oct 22, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, presented preclinical results of a robust and efficacious antimicrobial coating for orthopedic hardware at the 2014 Orthopaedic Trauma Association (OTA) Annual Meeting.
BONE: 3.20 (-0.33)
Bacterin Announces 3Demin(TM) Cortical Fibers
GlobeNewswire - Mon Oct 20, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the launch of a demineralized allograft, 3Demin(TM) Cortical Fibers.
BONE: 3.20 (-0.33)
CORRECTING AND REPLACING -- Bacterin Announces Preliminary Third Quarter 2014 Revenue
GlobeNewswire - Thu Oct 16, 9:46AM CDT
In a release issued on Tuesday, October 14th 2014 by Bacterin International Holdings, Inc. (NYSE MKT:BONE), there was an error in the third paragraph. Please note that the final sentence of the third paragraph should read, "We are now starting to realize the benefits of these investments and we expect to see our revenue accelerate during the fourth quarter of 2014 and throughout 2015."
BONE: 3.20 (-0.33)
Bacterin Announces Preliminary Third Quarter 2014 Revenue
GlobeNewswire - Tue Oct 14, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary, unaudited revenue for the third quarter of 2014.
BONE: 3.20 (-0.33)
Volcano Corp Banks on IVUS Portfolio amid Several Odds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 1:30PM CDT
On Oct 10, we issued an updated research report on leading precision guided therapy tools provider, Volcano Corporation (VOLC).
BONE: 3.20 (-0.33), HNSN: 0.80 (unch), VOLC: 11.20 (+0.12), EW: 126.80 (+0.57)
Bacterin CEO Dan Goldberger to be Guest on Fox Business Network's Opening Bell With Maria Bartiromo
GlobeNewswire - Thu Oct 02, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's Opening Bell with Maria Bartiromo at approximately 10:40 AM/ET on Friday, October 3, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products.
BONE: 3.20 (-0.33)
Edwards Lifesciences Up to Buy on Solid Q2, Strong Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 1:50PM CDT
Recently, Zacks Investment Research upgraded Edwards Lifesciences Corporation (EW) to a Zacks Rank #2 (Buy).
BONE: 3.20 (-0.33), HNSN: 0.80 (unch), EW: 126.80 (+0.57), HOLX: 26.61 (+0.24)
